-
Mashup Score: 0Press corner - 12 month(s) ago
Highlights, press releases and speeches
Categories: Latest Headlines, UrologyTweet
-
Mashup Score: 0Current policies on early detection of prostate cancer create overdiagnosis and inequity with minimal benefit - 12 month(s) ago
Informed choice approaches lead to high rates of unsystematic PSA testing, especially among those least likely to benefit and most likely to be harmed, argue Andrew Vickers and colleagues Screening for prostate cancer with prostate specific antigen (PSA) remains highly controversial because it is unclear whether the benefits of reduced prostate cancer mortality offset the harms of overdiagnosis…
Source: The BMJCategories: Latest Headlines, UrologyTweet-
And here is the @bmj_latest article on “informed choice” https://t.co/3WelG1m01A which it says “create overdiagnosis and inequity with minimal benefit”.
-
-
Mashup Score: 1Current policies on early detection of prostate cancer create overdiagnosis and inequity with minimal benefit - 12 month(s) ago
Informed choice approaches lead to high rates of unsystematic PSA testing, especially among those least likely to benefit and most likely to be harmed, argue Andrew Vickers and colleagues Screening for prostate cancer with prostate specific antigen (PSA) remains highly controversial because it is unclear whether the benefits of reduced prostate cancer mortality offset the harms of overdiagnosis…
Source: The BMJCategories: Hem/Oncs, Latest HeadlinesTweet-
You may want to read this article as well. https://t.co/elWQDuN077
-
-
Mashup Score: 1Press corner - 12 month(s) ago
Highlights, press releases and speeches
Categories: Hem/Oncs, Latest HeadlinesTweet-
Long term analysis of the European screening trial now justifies PSA screening and is recommending member states set this up https://t.co/lISyf5ydMM no need to wait for more evidence. UK NSC reviewing 🤞! https://t.co/RRNf8vZiD8
-
-
Mashup Score: 2The Uromigos • A podcast on Spotify for Podcasters - 12 month(s) ago
Broadcasting the latest developments in GU cancer
Source: Spotify for PodcastersCategories: Hem/Oncs, Latest HeadlinesTweet-
Delighted to talk about #Stampede on @Uromigos this evening. https://t.co/hxp9LTkHmQ
-
-
Mashup Score: 0The Doctor – issue 55, May 2023 - 12 month(s) ago
Read the latest issue of The Doctor magazine online
Categories: Hem/Oncs, Latest HeadlinesTweet-
This is the link to the article in the @TheBMA The Doctor magazine which explains what we are doing https://t.co/nJzkOnfA2t
-
-
Mashup Score: 1Current policies on early detection of prostate cancer create overdiagnosis and inequity with minimal benefit - 12 month(s) ago
Informed choice approaches lead to high rates of unsystematic PSA testing, especially among those least likely to benefit and most likely to be harmed, argue Andrew Vickers and colleagues Screening for prostate cancer with prostate specific antigen (PSA) remains highly controversial because it is unclear whether the benefits of reduced prostate cancer mortality offset the harms of overdiagnosis…
Source: The BMJCategories: Hem/Oncs, Latest HeadlinesTweet-
This is part of a suite on @nhse funded studies looking at ways to address the issue of men presenting late with advanced disease. GP provided "Informed choice" does not work - e.g. up to 35% in Scotland present with mets. See https://t.co/3WelG1m01A https://t.co/KYgGq6K34y
-
-
Mashup Score: 1Europe recommends screening programmes for prostate cancer - 12 month(s) ago
The voice of men with prostate cancer in Europe
Source: Europa UomoCategories: Hem/Oncs, Latest HeadlinesTweet-
The NSC is reviewing screening again. The EU just recommended in favour - see https://t.co/CgQBxSVdCh. Perjorative comments are unhelpful and frankly ill informed. This is a Cancer Network project with full local GP support. We will publish the analysis when complete.
-
-
Mashup Score: 0ESMO 2022: First Results from BladderPath: A Randomised Trial of MRI Versus Cystoscopic Staging for Newly Diagnosed Bladder Cancer - 1 year(s) ago
ESMO 2022 results of the novel BladderPath trial examining the role of magnetic resonance imaging (MRI) for bladder cancer staging, muscle invasive bladder cancer (MIBC), TURBT for NMIBC, treatment for MIBC patients.
Source: www.urotoday.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Not convinced. TURBT purely prognostic- completely debulked =T2 incompletely debulked =T3-4 hence the difference in outcomes. Delays definitive treatment, pro-metastatic and unpleasant. Norm in oncology is biopsy and image. https://t.co/Bq9h0jXR7O https://t.co/bvJwWVj0oK
-
-
Mashup Score: 0Chemoradiotherapy in Muscle-invasive Bladder Cancer: 10-yr Follow-up of the Phase 3 Randomised Controlled BC2001 Trial - 1 year(s) ago
BC2001, the largest randomised trial of bladder-sparing treatment for muscle-invasive bladder cancer (MIBC), demonstrated improvement in locoregional …
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Here’s the best data on this. 10 year follow up data from BC2001 (RT vs RT/5FU-MMC). 30% about the rate for RT only. Half the rate if you give chemoRT (as of course you should - see paper) https://t.co/tGc8Emxxcv https://t.co/RQwAtCVowy https://t.co/pJd3DY0ghN
-
Here is the latest analysis on the screening evidence https://t.co/lISyf5ydMM https://t.co/GXYK1dSI6R